Literature DB >> 27050953

Role of single nucleotide polymorphisms of DNA repair genes in susceptibility to pancreatic cancer in Chinese population.

M F Ying1, R Zhao1.   

Abstract

We conducted a case-control study to investigate the role of ERCC1-ERCC5 gene polymorphisms in the risk of pancreatic cancer. This study included 195 patients who were newly diagnosed with histopathologically confirmed primary pancreatic cancer, and 254 controls were recruited from Sir Run Run Shaw Hospital, between January 2012 and December 2014. Genotyping of ERCC1 rs3212986 and rs11615, ERCC2 rs13181, ERCC3 rs4150441, ERCC4 rs6498486, and ERCC5 rs2094258 polymorphisms was carried out using polymerase chain reaction coupled with restriction fragment length polymorphism. Unconditional logistic regression analyses showed that the TT genotype of ERCC1 rs3212986 was associated with an increased risk of pancreatic cancer, and the OR (95%CI) was 2.26 (1.21-4.22). However, we did not find a significant association between ERCC1 rs11615, ERCC2 rs13181, ERCC3 rs4150441, ERCC4 rs6498486, and ERCC5 rs2094258 polymorphisms and risk of pancreatic cancer. In summary, we found that the presence of the ERCC1 rs3212986 polymorphism correlated with an increased risk of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27050953     DOI: 10.4238/gmr.15017273

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  5 in total

1.  ERCC5 rs751402 polymorphism is the risk factor for sporadic breast cancer in Thailand.

Authors:  Malinee Pongsavee; Kamol Wisuwan
Journal:  Int J Mol Epidemiol Genet       Date:  2018-08-20

2.  Association between ERCC2 Lys751Gln polymorphism and the risk of pancreatic cancer, especially among Asians: evidence from a meta-analysis.

Authors:  Yang Wu; Zi-Peng Lu; Jing-Jing Zhang; Dong-Fang Liu; Guo-Dong Shi; Chun Zhang; Zhi-Qiang Qin; Jian-Zhong Zhang; Yuan He; Peng-Fei Wu; Yi Miao; Kui-Rong Jiang
Journal:  Oncotarget       Date:  2017-07-25

3.  XPG gene polymorphisms and cancer susceptibility: evidence from 47 studies.

Authors:  Jiawen Huang; Xiaoqi Liu; Ling-Ling Tang; Jian-Ting Long; Jinhong Zhu; Rui-Xi Hua; Jufeng Li
Journal:  Oncotarget       Date:  2017-06-06

4.  Genetic polymorphisms and pancreatic cancer risk: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Peng Dai; Jing Li; Weibin Li; Xueliang Qin; Xiaoyong Wu; Weidong Di; Yanzhong Zhang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

5.  A systematic review and network meta-analysis of single nucleotide polymorphisms associated with pancreatic cancer risk.

Authors:  Zhuo-Miao Ye; Li-Juan Li; Ming-Bo Luo; Hong-Yuan Qing; Jing-Hui Zheng; Chi Zhang; Yun-Xin Lu; You-Ming Tang
Journal:  Aging (Albany NY)       Date:  2020-11-20       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.